NCT02459262View on ClinicalTrials.gov

Safety and Immunogenicity of a Group B Streptococcus Vaccine in Non-pregnant Women 18-40 Years of Age.

PHASE1CompletedINTERVENTIONAL
Enrollment

240

Participants

Timeline

Start Date

May 31, 2015

Primary Completion Date

April 12, 2017

Study Completion Date

April 21, 2017

Conditions
Infection by Streptococcus Group B
Interventions
BIOLOGICAL

GBS-NN vaccine

Three dose levels will be administered, with and without Alhydrogel®

Trial Locations (1)

BT2 7BA

Biokinetic Europ Ltd, Belfast

Sponsors

Lead Sponsor

Minervax ApS
All Listed Sponsors
lead

Minervax ApS

OTHER

NCT02459262 - Safety and Immunogenicity of a Group B Streptococcus Vaccine in Non-pregnant Women 18-40 Years of Age. | Biotech Hunter | Biotech Hunter